The estimated Net Worth of Joseph C Caldarella is at least $10.1 Million dollars as of 6 September 2017. Joseph Caldarella owns over 9,340 units of Bristol-Myers Squibb Co stock worth over $2,249,571 and over the last 17 years Joseph sold BMY stock worth over $7,806,853.
Joseph has made over 37 trades of the Bristol-Myers Squibb Co stock since 2009, according to the Form 4 filled with the SEC. Most recently Joseph sold 9,340 units of BMY stock worth $560,400 on 6 September 2017.
The largest trade Joseph's ever made was exercising 40,308 units of Bristol-Myers Squibb Co stock on 20 February 2013 worth over $1,012,940. On average, Joseph trades about 9,806 units every 74 days since 2008. As of 6 September 2017 Joseph still owns at least 46,297 units of Bristol-Myers Squibb Co stock.
You can see the complete history of Joseph Caldarella stock trades at the bottom of the page.
Over the last 17 years, insiders at Bristol-Myers Squibb Co have traded over $318,151,721 worth of Bristol-Myers Squibb Co stock and bought 211,503 units worth $6,601,565 . The most active insiders traders include Lamberto Andreotti, James M Cornelius, and Giovanni Caforio. On average, Bristol-Myers Squibb Co executives and independent directors trade stock every 8 days with the average trade being worth of $1,682,720. The most recent stock trade was executed by Cari Gallman on 1 August 2024, trading 1,061 units of BMY stock currently worth $51,554.
The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the worlds largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.
Bristol-Myers Squibb Co executives and other stock owners filed with the SEC include: